BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32500925)

  • 1. Complete remission and proviral load negativization after allogeneic-SCT in a patient with Adult T-cell lymphoma: Case report.
    Warley F; Cristaldo N; Barcan L; Valledor A; GarcĂ­a-Rivello H; Arbelbide J; Basquiera AL; Otero V
    Transpl Infect Dis; 2020 Dec; 22(6):e13350. PubMed ID: 32500925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adult T-cell leukemia-lymphoma.
    Tsukasaki K
    Hematology; 2012 Apr; 17 Suppl 1():S32-5. PubMed ID: 22507774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete remission in two cases of adult T-cell leukemia/lymphoma treated with hyper-CVAD: a case report and review of the literature.
    Alduaij A; Butera JN; Treaba D; Castillo J
    Clin Lymphoma Myeloma Leuk; 2010 Dec; 10(6):480-3. PubMed ID: 21156467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult T-Cell Leukemia/Lymphoma: Rarely Encountered in the United States.
    Roe C; Komrokji R; Zhang L; Price S; Sokol L
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S191-4. PubMed ID: 27521318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of the Modified EPOCH Regimen (Etoposide, Vincristine, Doxorubicin, Carboplatin, and Prednisolone) for Adult T-cell Leukemia/Lymphoma: A Multicenter Retrospective Study.
    Tsukamoto Y; Kiyasu J; Choi I; Kozuru M; Uike N; Utsunomiya H; Hirata A; Fujioka E; Ohno H; Nakashima E; Nakashima Y; Miyashita K; Tachikawa Y; Narazaki T; Tsuda M; Haji S; Takamatsu A; Tanaka E; Goto T; Takatsuki H; Oyama M; Muta H; Yagi Y; Ikeda M; Matsushima T; Yufu Y; Suehiro Y
    Clin Lymphoma Myeloma Leuk; 2020 Jul; 20(7):e445-e453. PubMed ID: 32312633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes after hematopoietic SCT for adult T-cell leukemia/lymphoma: results of prospective trials.
    Choi I; Tanosaki R; Uike N; Utsunomiya A; Tomonaga M; Harada M; Yamanaka T; Kannagi M; Okamura J;
    Bone Marrow Transplant; 2011 Jan; 46(1):116-8. PubMed ID: 20400987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [International consensus on the management of adult T-cell leukemia-lymphoma].
    Tsukasaki K
    Rinsho Ketsueki; 2010 Jul; 51(7):493-9. PubMed ID: 20693768
    [No Abstract]   [Full Text] [Related]  

  • 8. Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma.
    Ratner L; Rauch D; Abel H; Caruso B; Noy A; Barta SK; Parekh S; Ramos JC; Ambinder R; Phillips A; Harding J; Baydoun HH; Cheng X; Jacobson S
    Blood Cancer J; 2016 Mar; 6(3):e408. PubMed ID: 27015285
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of adult T-cell leukemia-lymphoma].
    Fukushima T
    Rinsho Ketsueki; 2014 Oct; 55(10):1952-61. PubMed ID: 25297760
    [No Abstract]   [Full Text] [Related]  

  • 11. A retrospective analysis of allogeneic hematopoietic stem cell transplantation for adult T cell leukemia/lymphoma (ATL): clinical impact of graft-versus-leukemia/lymphoma effect.
    Shiratori S; Yasumoto A; Tanaka J; Shigematsu A; Yamamoto S; Nishio M; Hashino S; Morita R; Takahata M; Onozawa M; Kahata K; Kondo T; Ota S; Wakasa K; Sugita J; Koike T; Asaka M; Kasai M; Imamura M
    Biol Blood Marrow Transplant; 2008 Jul; 14(7):817-23. PubMed ID: 18541202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning for adult T cell leukemia/lymphoma: impact of antithymocyte globulin on clinical outcome.
    Tanosaki R; Uike N; Utsunomiya A; Saburi Y; Masuda M; Tomonaga M; Eto T; Hidaka M; Harada M; Choi I; Yamanaka T; Kannagi M; Matsuoka M; Okamura J
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):702-8. PubMed ID: 18489996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult T-cell leukemia/lymphoma in a Korean--a case report.
    Lee SS; Hong SI; Lee DS; Kang YK; Kim CW; Jang JJ
    J Korean Med Sci; 1994 Dec; 9(6):458-65. PubMed ID: 7786441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous and allogeneic stem cell transplantation: rising therapeutic promise for mantle cell lymphoma.
    Tam CS; Khouri IF
    Leuk Lymphoma; 2009 Aug; 50(8):1239-48. PubMed ID: 19562639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Features and Treatment Outcomes of 81 Patients with Aggressive Type Adult T-cell Leukemia-lymphoma at a Single Institution over a 7-year Period (2006-2012).
    Kawano N; Yoshida S; Kuriyama T; Tahara Y; Yamashita K; Nagahiro Y; Kawano J; Koketsu H; Toyofuku A; Manabe T; Beppu K; Ono N; Himeji D; Yokota-Ikeda N; Inoue S; Ochiai H; Sonoda KH; Shimoda K; Ishikawa F; Ueda A
    Intern Med; 2015; 54(12):1489-98. PubMed ID: 26073237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How I treat adult T-cell leukemia/lymphoma.
    Cook LB; Phillips AA
    Blood; 2021 Jan; 137(4):459-470. PubMed ID: 33075812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of HTLV-1-associated acute adult T-cell leukaemia lymphoma by allogeneic bone marrow transplantation.
    Borg A; Yin JA; Johnson PR; Tosswill J; Saunders M; Morris D
    Br J Haematol; 1996 Sep; 94(4):713-5. PubMed ID: 8826899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adult T-cell leukemia/lymphoma].
    Yoshimitsu M
    Rinsho Ketsueki; 2023; 64(9):1032-1040. PubMed ID: 37899180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small number of HTLV-1-positive cells frequently remains during complete remission after allogeneic hematopoietic stem cell transplantation that are heterogeneous in origin among cases with adult T-cell leukemia/lymphoma.
    Yamasaki R; Miyazaki Y; Moriuchi Y; Tsutsumi C; Fukushima T; Yoshida S; Taguchi J; Inoue Y; Matsuo E; Imaizumi Y; Imanishi D; Fujimoto T; Tsushima H; Honda S; Hata T; Tsukasaki K; Tomonaga M
    Leukemia; 2007 Jun; 21(6):1212-7. PubMed ID: 17410191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHOP versus CHOP plus ESHAP and high-dose therapy with autologous peripheral blood progenitor cell transplantation for high-intermediate-risk and high-risk aggressive non-Hodgkin's lymphoma.
    Intragumtornchai T; Prayoonwiwat W; Numbenjapon T; Assawametha N; O'Charoen R; Swasdikul D
    Clin Lymphoma; 2000 Dec; 1(3):219-25. PubMed ID: 11707834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.